| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mothers and Babies Research Centre, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, University of Newcastle, NSW, Australia
* To whom correspondence should be addressed. E-mail: vicki.clifton{at}newcastle.edu.au.
The environment in which the fetus develops is critical for its survival and long term health. The regulation of normal human fetal growth involves many multi-directional interactions between the mother, placenta and fetus. The mother supplies nutrients and oxygen to the fetus via the placenta. The fetus influences the provision of maternal nutrients via the placental production of hormones which regulate maternal metabolism. The placenta is the site of exchange between mother and fetus and regulates fetal growth via the production and metabolism of growth regulating hormones such as insulin-like growth factors (IGFs) and glucocorticoids. Adequate trophoblast invasion in early pregnancy and increased uteroplacental blood flow ensure sufficient growth of the uterus, placenta and fetus. The placenta may respond to fetal endocrine signals to increase transport of maternal nutrients by growth of the placenta, by activation of transport systems and by production of placental hormones to influence maternal physiology and even behavior. There are consequences of poor fetal growth both in the short term and long term, in the form of increased mortality and morbidity. Endocrine regulation of fetal growth involves interactions between the mother, placenta and fetus, and these effects may program long term physiology.
-hydroxysteroid dehydrogenase
low birth weight
fetal programming
This article has been cited by other articles:
![]() |
S. Cnattingius, S. Eloranta, H.-O. Adami, O. Axelsson, P. W. Dickman, C.-c. Hsieh, L. A. Mucci, D. Trichopoulos, M. Lambe, and A. L.V. Johansson Placental Weight and Risk of Invasive Epithelial Ovarian Cancer with an Early Age of Onset Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2344 - 2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Michael and A. T. Papageorghiou Potential significance of physiological and pharmacological glucocorticoids in early pregnancy Hum. Reprod. Update, September 1, 2008; 14(5): 497 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Scholz and J. L. Segar Cardiac Metabolism in the Fetus and Newborn NeoReviews, March 1, 2008; 9(3): e109 - e118. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chiesa, J. F. Osborn, C. Haass, F. Natale, M. Spinelli, E. Scapillati, A. Spinelli, and L. Pacifico Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry? Clin. Chem., March 1, 2008; 54(3): 550 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Coutinho, R. R. D. Coletta, E. M. F. Costa, P. R. Pachi, M. C. S. Boguszewski, D. Damiani, B. B. Mendonca, I. J. P. Arnhold, and A. A. L. Jorge Polymorphisms Identified in the Upstream Core Polyadenylation Signal of IGF1 Gene Exon 6 Do Not Cause Pre- and Postnatal Growth Impairment J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4889 - 4892. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Netchine, S. Rossignol, M.-N. Dufourg, S. Azzi, A. Rousseau, L. Perin, M. Houang, V. Steunou, B. Esteva, N. Thibaud, et al. 11p15 Imprinting Center Region 1 Loss of Methylation Is a Common and Specific Cause of Typical Russell-Silver Syndrome: Clinical Scoring System and Epigenetic-Phenotypic Correlations J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3148 - 3154. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Milne, C. L. Laurvick, E. Blair, C. Bower, and N. de Klerk Fetal Growth and Acute Childhood Leukemia: Looking Beyond Birth Weight Am. J. Epidemiol., July 15, 2007; 166(2): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Karlberg, H. Jalanko, and M. Lipsanen-Nyman Growth and Growth Hormone Therapy in Subjects With Mulibrey Nanism Pediatrics, July 1, 2007; 120(1): e102 - e111. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter Small for Gestational Age: Short Stature and Beyond Endocr. Rev., April 1, 2007; 28(2): 219 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. McGillivray, V. G. Thackray, D. Coss, and P. L. Mellon Activin and Glucocorticoids Synergistically Activate Follicle-Stimulating Hormone {beta}-Subunit Gene Expression in the Immortalized L{beta}T2 Gonadotrope Cell Line Endocrinology, February 1, 2007; 148(2): 762 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wu, F. W. Bazer, J. M. Wallace, and T. E. Spencer BOARD-INVITED REVIEW: Intrauterine growth retardation: Implications for the animal sciences J Anim Sci, September 1, 2006; 84(9): 2316 - 2337. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |